SIA FUNDS, EL FONDO QUE CONFÍA EN GRÍFOLS SE POSICIONA EN CONTRA DE LA OPA .: PharmaMar (OTCMKTS:PHMMF) Upgraded by Zacks Investment Research to Buy . They Currently Have $5.00 Target Price on the Stock.